*This presentation is no longer eligible for the 1 CE credit*
Medication-assisted treatment (MAT) refers to the practice of integrating counseling and medication to treat substance use disorders. Buprenorphine is one of three medications that are FDA-approved to treat opioid use disorders. The use of buprenorphine beyond the acute withdrawal period is still debated by some addiction treatment providers, despite the strong evidence base that suggests this medication helps many people to sustain recovery.
In this presentation, Harmony’s Medical Director and Chief Clinical Officer will discuss the process and outcomes of the effort to best utilize buprenorphine within the context of comprehensive recovery plans for appropriate individuals. Continue reading “Buprenorphine: Friend or Foe?”